SPINT2
Basic information
Region (hg38): 19:38244035-38292615
Links
Phenotypes
GenCC
Source:
- congenital secretory sodium diarrhea 3 (Strong), mode of inheritance: AR
- congenital secretory sodium diarrhea 3 (Moderate), mode of inheritance: AR
- congenital secretory sodium diarrhea 3 (Strong), mode of inheritance: AR
- syndromic congenital sodium diarrhea (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies | AD | Gastrointestinal | Due to fecal sodium loss, individuals may present with severe (potentially lethal) secretory diarrhea and related electrolyte/metabolic derangements, including hyponatremic metabolic acidosis, and recognition may allow appropriate medical management, which includes parenteral nutrition (weaning from parenteral nutrition, with oral sodium citrate supplementation, is possible in childhood | Craniofacial; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Ophthalmologic | 11113072; 17786112; 19185281; 20009592 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (147 variants)
- Inborn_genetic_diseases (25 variants)
- Congenital_secretory_sodium_diarrhea_3 (15 variants)
- SPINT2-related_disorder (7 variants)
- Congenital_sodium_diarrhea (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPINT2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000021102.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 45 | 48 | ||||
| missense | 51 | 63 | ||||
| nonsense | 1 | |||||
| start loss | 3 | 3 | ||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 7 | |||||
| Total | 10 | 7 | 54 | 50 | 5 |
Highest pathogenic variant AF is 0.00019660403
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SPINT2 | protein_coding | protein_coding | ENST00000301244 | 7 | 48580 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000751 | 0.931 | 125726 | 0 | 22 | 125748 | 0.0000875 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.997 | 118 | 153 | 0.773 | 0.00000960 | 1631 |
| Missense in Polyphen | 25 | 36.717 | 0.68088 | 436 | ||
| Synonymous | 0.477 | 60 | 64.9 | 0.925 | 0.00000400 | 517 |
| Loss of Function | 1.61 | 7 | 13.4 | 0.523 | 6.84e-7 | 145 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000905 | 0.0000905 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000149 | 0.000149 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibitor of HGF activator. Also inhibits plasmin, plasma and tissue kallikrein, and factor XIa.;
- Disease
- DISEASE: Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies (DIAR3) [MIM:270420]: A disease characterized by life-threatening secretory diarrhea, severe metabolic acidosis and hyponatremia. Hyponatremia is secondary to extraordinarily high fecal sodium loss, with low or normal excretion of urinary sodium, in the absence of infectious, autoimmune and endocrine causes. {ECO:0000269|PubMed:19185281}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signal Transduction;MET Receptor Activation;Signaling by MET;Signaling by MST1;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.335
Intolerance Scores
- loftool
- 0.664
- rvis_EVS
- 0.44
- rvis_percentile_EVS
- 77.7
Haploinsufficiency Scores
- pHI
- 0.100
- hipred
- N
- hipred_score
- 0.210
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spint2
- Phenotype
- limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- neural tube closure;establishment or maintenance of cell polarity;negative regulation of endopeptidase activity;negative regulation of cell-cell adhesion;epithelial cell morphogenesis involved in placental branching;basement membrane organization;cellular response to BMP stimulus;negative regulation of cell motility;negative regulation of neural precursor cell proliferation
- Cellular component
- extracellular region;cytoplasm;plasma membrane;integral component of membrane
- Molecular function
- endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity